CD14 (Monocyte/Macrophage Marker) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CD14 (Monocyte/Macrophage Marker) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD14 (Monocyte/Macrophage Marker) |
| Clone | polyclonal |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | n/a |
| Format | purified |
| Size | 0.02 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (Without BSA & Azide at 1mg/ml) |
| Concentration | n/a |
| Applications | Immunohistochemistry (IHC) Paraffin |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Recognizes a protein of 55kDa, identified as CD14 (also known lipopolysaccharide receptor). CD14 is expressed strongly on monocytes and macrophage and weakly on the surface of neutrophils. CD14 is anchored to cells by linkage to glycosylphosphatidylinositol (GPI) and functions as a high affinity receptor for complexes of LPS and LPS binding protein (LBP). Soluble CD14, also binding to LPS, acts at physiological concentration as an LPS agonist and has, at higher concentrations, an LPS antagonizing effect in cell activation. |
| Immunogen | Immunogen: Recombinant fragment of human CD14 protein (around aa 25-148) (exact sequence is proprietary) |
| Other Names | [Lipopolysaccharide receptor; Mo2; Monocyte Differentiation Antigen 14; Myeloid cell-specific leucine-rich glycoprotein] |
| Gene, Accession # | [CD14], Gene ID: 929, NCBI: NP_000582.1, UniProt: P08571 |
| Catalog # | MBS4381404 |
| Price | $190, $340, $340 |
| Order / More Info | CD14 (Monocyte/Macrophage Marker) Antibody from MYBIOSOURCE INC. |
| Product Specific References | Simmons, D.L., et al. 1989. Blood 73: 284 |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies